Left field announcement today. I am a bit confused as to why management would want to acquire a lithium brine project. My thoughts are as follows:
- Is this possibly a JV with another lithium brine explorer? If so, who would be covering all the costs?
- If Morabisi is really that good... then why diversify into brine? - which honestly takes a long time to get to market. Unless they have their doubts about Morabisi?
This brine project would simply take money away from exploration of Morabisi and the time and focus of management... All this while working on the fertiliser project.
- I've seen time and time again when companies start over-diversifying, it generally points to disbelief in the quality of their existing projects. I.e: AGY/PLP/DKO. Jack of all trades, but a master of none. If one truly believes they have a gem, they would work on it.
If I was a holder, I would be absolutely pi*sed off that they would want to put their resources to another project... Let alone a brine project. More resources required.. More CR... More dilution etc etc. The technical difficulties of bringing a brine project to market cannot be understated.
Just my 2c.
- Forums
- ASX - By Stock
- GNM
- Ann: Trading Halt
Ann: Trading Halt, page-117
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GNM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.855M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 674997 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 23334 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 674997 | 0.011 |
5 | 1329995 | 0.010 |
3 | 883330 | 0.009 |
2 | 440000 | 0.008 |
2 | 229999 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 23334 | 1 |
0.015 | 202325 | 1 |
0.016 | 12803 | 1 |
0.017 | 227673 | 2 |
0.018 | 416660 | 3 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
GNM (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online